These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 25985434)

  • 21. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
    Siva A; Saip S; Altintas A; Jacob A; Keegan BM; Kantarci OH
    Mult Scler; 2009 Aug; 15(8):918-27. PubMed ID: 19667020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in multiple sclerosis: cytokines and vitamin D.
    Eikelenboom MJ; Killestein J; Kragt JJ; Uitdehaag BM; Polman CH
    J Neurol Sci; 2009 Nov; 286(1-2):40-2. PubMed ID: 19656528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D and multiple sclerosis: review of a possible association.
    Summerday NM; Brown SJ; Allington DR; Rivey MP
    J Pharm Pract; 2012 Feb; 25(1):75-84. PubMed ID: 21987526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Zinc concentration in the central nervous system in a case of multiple sclerosis--comparison with other neurological diseases].
    Yasui M; Kihira T; Ota K; Mukoyama M; Adachi K; Sasajima K; Iwata S
    No To Shinkei; 1991 Oct; 43(10):951-5. PubMed ID: 1799499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D as an immune modulator in multiple sclerosis, a review.
    Smolders J; Damoiseaux J; Menheere P; Hupperts R
    J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis.
    Smolders J; Peelen E; Thewissen M; Menheere P; Tervaert JW; Hupperts R; Damoiseaux J
    Autoimmun Rev; 2009 Jun; 8(7):621-6. PubMed ID: 19393206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: implications in multiple sclerosis.
    Chesik D; De Keyser J; Wilczak N
    Cytokine Growth Factor Rev; 2007; 18(3-4):267-78. PubMed ID: 17485236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of vitamin D in the pathogenesis and course of multiple sclerosis].
    Góral A; Brola W; Kasprzyk M; Przybylski W
    Wiad Lek; 2015; 68(1):60-6. PubMed ID: 26094335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.
    Franciotta D; Di Stefano AL; Jarius S; Zardini E; Tavazzi E; Ballerini C; Marchioni E; Bergamaschi R; Ceroni M
    J Neuroimmunol; 2011 Jan; 230(1-2):160-3. PubMed ID: 21109310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for an Association Between Vitamin D and Multiple Sclerosis.
    Pakpoor J; Ramagopalan S
    Curr Top Behav Neurosci; 2015; 26():105-15. PubMed ID: 25502544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Relationship of opticomyelitis and diffuse sclerosis].
    Marchenkova RL; Komandenko NI; Skoromets AA
    Sov Med; 1978 Jul; (7):63-7. PubMed ID: 694578
    [No Abstract]   [Full Text] [Related]  

  • 32. Multiple sclerosis, osteoporosis, and vitamin D.
    Sioka C; Kyritsis AP; Fotopoulos A
    J Neurol Sci; 2009 Dec; 287(1-2):1-6. PubMed ID: 19800081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D Supplementation as Add-on Therapy in Multiple Sclerosis-Balance between Benefit and Risk?: A Commentary on Vitamin D Supplementation in Central Nervous System Demyelinating Disease-Enough Is Enough.
    Goischke HK
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30917564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D status and age of onset of demyelinating disease.
    Brenton JN; Koenig S; Goldman MD
    Mult Scler Relat Disord; 2014 Nov; 3(6):684-8. PubMed ID: 25891547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D-gene interactions in multiple sclerosis.
    Berlanga-Taylor AJ; Disanto G; Ebers GC; Ramagopalan SV
    J Neurol Sci; 2011 Dec; 311(1-2):32-6. PubMed ID: 22000399
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors.
    Sellner J; Kraus J; Awad A; Milo R; Hemmer B; Stüve O
    Autoimmun Rev; 2011 Jun; 10(8):495-502. PubMed ID: 21354338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
    Faridar A; Eskandari G; Sahraian MA; Minagar A; Azimi A
    Acta Neurol Belg; 2012 Dec; 112(4):327-33. PubMed ID: 22767049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D in multiple sclerosis: implications for assessment and treatment.
    Holmøy T; Kampman MT; Smolders J
    Expert Rev Neurother; 2012 Sep; 12(9):1101-12. PubMed ID: 23039389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing vitamin D in the central nervous system.
    Holmøy T; Moen SM
    Acta Neurol Scand Suppl; 2010; (190):88-92. PubMed ID: 20586743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocannabinoid system in targeting inflammatory neurodegenerative diseases.
    Centonze D; Finazzi-Agrò A; Bernardi G; Maccarrone M
    Trends Pharmacol Sci; 2007 Apr; 28(4):180-7. PubMed ID: 17350694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.